ABIVAX Société Anonyme

€77.15As of Sun 8 Nov 2026, 12:00 UTC
EPA:ABVXHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR 26.65%
Div yield —
ROE (252.35%)
Biotechnology
Beta (5Y) (0.33)
PE TTM —
TSR TTM (14.58%)
Mkt cap €6.726B
ROIC (87.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€90
16.53%
(84.32%)
Hold 4|8|1|5|8
4Q25
1Q26
2Q26
3Q26
Earnings per share€
1.32
1.39
1.54
1.54
3.44%
14.36%
17.96%
13.20%
Revenue€M
304.5
312.1
326.5
326.1
7.55%
4.09%
8.37%
8.41%
Peers (US$7.552B)
Cap (US$)
PE
1.540B
—
1.147B
—
902.0M
—
Capital
TTM
5Y
10Y
Leveragex
1.462
0.161
0.160
EBIT/Intx
1.270
1.084
1.251
Own earn%
(205.64)
(106.42)
(92.73)
Sh yield%
29.70
58.46
58.61
Owners
Insiders/Inst%
0.19
79.06
Short interest%
0.91
SBC / revenue%
3.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
6–11
$1 testx
0.0
Incr. ROIC%
0